Skip to main content
. 2011 Nov 18;287(2):1178–1188. doi: 10.1074/jbc.M111.272393

FIGURE 3.

FIGURE 3.

Enhanced liver fibrosis in ASMase−/− mice after CCl4 administration was ameliorated after CtsB inhibition. A–D, serum alanine transaminase (ALT) levels (A), CtsB activity (B), CtsD and α-SMA protein expression (C), and hydroxyproline levels in liver homogenate (D). E, α-SMA immunostaining of liver section at ×40 magnification. Data are mean ± S.E. (error bars), n = 6 animals/group. *, p ≤ 0.05 versus vehicle-treated mice; #, p ≤ 0.05 versus CCl4 ASMase−/−-treated mice.